The France Journal
SEE OTHER BRANDS

The top news stories from France

The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on May 27, 2025

OTC Markets Group accueille Exail Technologies, société européenne de défense, sur le marché OTCQX

OTC Markets Group accueille Exail Technologies, société européenne de défense, sur le marché OTCQX

NEW YORK, 27 mai 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), opérateur de marchés réglementés pour la négociation de plus de 12,000 titres américains et internationaux, a annoncé qu'Exail Technologies (Euronext Paris: EXA; OTCQX: EXALF), …

Nokia accelerates mass market multi-Gig broadband with new high-density 25G PON line card

Nokia accelerates mass market multi-Gig broadband with new high-density 25G PON line card

Press Release Nokia accelerates mass market multi-Gig broadband with new high-density 25G PON line card The new 16-port line card solution is optimized for mass market 25G PON, ensuring multi-gigabit can be delivered in a cost-effective way to everyone …

Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 Clinical Trials in Japan

Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 Clinical Trials in Japan

Exclusive Japanese partner Kowa has received regulatory approval to initiate Phase 3 clinical trials on NCX 470 for the treatment of ocular hypertension in Japan Milestone payments from Kowa totaling €3 million expected to be received by Nicox in 2025 …

Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025, alors que NCX 470 se prépare à entrer en essais cliniques de Phase 3 au Japon

Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025, alors que NCX 470 se prépare à entrer en essais cliniques de Phase 3 au Japon

27 mai 2025 – publication à 7H30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société internationale spécialisée en ophtalmologie, annonce aujourd’hui que son partenaire exclusif au Japon pour NCX …

Vallourec Announces Share Repurchase Program

Vallourec Announces Share Repurchase Program

Press release VALLOUREC ANNOUNCES SHARE REPURCHASE PROGRAM Meudon (France), May 27, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces its intention to repurchase shares. Vallourec intends to execute a buyback in the amount …

VALLOUREC ANNONCE UN PROGRAMME DE RACHAT D’ACTIONS

VALLOUREC ANNONCE UN PROGRAMME DE RACHAT D’ACTIONS

Communiqué de presse VALLOUREC ANNONCE UN PROGRAMME DE RACHAT D’ACTIONS Meudon (France), 27 mai, 2025 – Vallourec, leader mondial des solutions tubulaires premium sans soudure, annonce son intention de racheter des actions. Vallourec a l'intention de …

Press Release: Sanofi completes acquisition of DR-0201

Press Release: Sanofi completes acquisition of DR-0201

Sanofi completes acquisition of DR-0201 Paris, May 27, 2025. Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., a private clinical-stage biopharmaceutical company. The acquisition …

Communiqué de presse : Sanofi finalise l’acquisition du DR-0201

Communiqué de presse : Sanofi finalise l’acquisition du DR-0201

Sanofi finalise l’acquisition du DR-0201 Paris, le 27 mars 2025. Sanofi annonce la finalisation de l’acquisition du DR-0201, un anticorps bispécifique ciblé qui engage les cellules myéloïdes, à Dren Bio, Inc., société biopharmaceutique privée au stade …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service